Literature DB >> 6170263

Antiproliferative and antiviral activities of human leukocyte interferons.

M Evinger, M Rubinstein, S Pestka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6170263     DOI： 10.1016/0003-9861(81)90195-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  13 in total

1.  Synthesis and expression of recombinant interferon alpha-5 gene in tobacco chloroplasts, a non-edible plant.

Authors:  Muhammad Sarwar Khan; Farwa Nurjis
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 3.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells.

Authors:  R Petryshyn; J J Chen; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.

Authors:  B H Morrison; J A Bauer; D V Kalvakolanu; D J Lindner
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

6.  Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

Authors:  P B Fisher; A F Miranda; L E Babiss; S Pestka; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Pleiotropic activities of human interferons are mediated by multiple response pathways.

Authors:  R L Forti; W M Mitchell; W C Hubbard; R J Workman; J T Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma.

Authors:  U Elsässer-Beile; N Drees; H A Neumann; E Schöpf
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

9.  Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.

Authors:  Carolina Scagnolari; Milvia Casato; Francesca Bellomi; Francesca De Pisa; Ombretta Turriziani; Rossella Coviello; Maria Rosaria Pirro; Ferdinando Dianzani; Guido Antonelli
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.

Authors:  H Arnheiter; M Ohno; M Smith; B Gutte; K C Zoon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.